by David Kent | May 28, 2013
. A few weeks ago, Italian private company Stamina came under considerable pressure regarding their controversial use of mesenchymal stem cells in patients. The Italian government, it seems, had authorized an unproven stem cell therapy for use in patients. The...
by David Kent | Apr 30, 2013
. Stem cells must strike a balance between different types of divisional outcomes in order to provide the correct numbers and types of cells for the lifetime of an organism. At each cell division, a stem cell either makes two replicates of itself to expand the...
by David Kent | Dec 7, 2010
My last post was mostly centred on the lack of openness displayed by a growing number of scientists, but failed to comment on the wonderful array of findings that were presented by world leaders in stem cell biology. The Royal Society Meeting that took place in...
by David Kent | Nov 10, 2010
One of the most memorable moments of my PhD training was at a 2006 Keystone conference where Shinya Yamanaka presented a little something called Pluripotency and Nuclear Reprogramming. He carefully presented the transcription factor screen that would culminate in the...
Comments